In LLC xenograft mice, endostatin inhibited tumor angiogenesis by reducing the number of CD31+ cells and VEGF expression, aggravated hypoxia, and increased levels of inflammatory cytokines (IL-4, IL-6, IL-10) in tumor and CCL2 expression in endothelial cells and fibroblasts [224]. The gene discussed is IL10; the disease is neoplasm.